Advertisement

Topics

Strategies for the US Clinical Chemistry and Immunodiagnostics Market 2015

20:00 EDT 2 Jun 2015 | Globe Newswire

Dublin, June 03, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/h9d8lp/2015_strategies) has announced the addition of the "2015 Strategies for the US Clinical Chemistry and Immunodiagnostics Market" report to their offering.

2015 Strategies for the US Clinical Chemistry and Immunodiagnostics Market: Sales Forecasts, Supplier Shares, Competitive Strategies is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the nextfive years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers; sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

The companies analyzed in the report include:

  • Abbott, AdnaGen, Agilent, Alere, Beckman Coulter/Danaher, Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin, Eiken, Fujirebio/Innogenetics, IL, Kyowa Medex, Ortho-Clinical Diagnotics, Roche, Siemens, Sysmex, Thermo Fisher, Tosoh, Wako, Wallac/PE.

Tests Analyzed in the Report:

  • Routine Clinical Chemistry
  • Therapeutic Drug Monitoring (TDM)
  • Endocrine Function
  • Tumor Markers and Special Chemistry
  • Immunoproteins
  • Drugs of Abuse

For more information visit http://www.researchandmarkets.com/research/h9d8lp/2015_strategies




CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: In Vitro Diagnostics

Primary Logo

NEXT ARTICLE

More From BioPortfolio on "Strategies for the US Clinical Chemistry and Immunodiagnostics Market 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...